CYTK Edward M Kaye MD sells $337K worth of shares
Nov 13, 2025, 5:36 AM
0.00%
What does CYTK do
Cytokinetics, a South San Francisco-based biopharmaceutical company, develops muscle activators and inhibitors for diseases affecting muscle performance, with key drug candidates including aficamten and omecamtiv mecarbil. Founded in 2004, it employs 423 people and specializes in cardiac muscle function.
Edward M Kaye MD sold 5,175 shares of CYTK on 11 November at $65.08 per share, worth a total of $337K. They now own 9,977 CYTK shares, or a 34% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.